• HOME
  • LOGIN
  • JOIN

사이트 메뉴

  • 회사소개
    • ABOUT US
    • ABOUT US(영문)
    • CEO 인사말
    • 연혁
    • 조직도
  • 제품소개
    • HT-3000
    • Hydrosun(하이드로선)
      1. - 의료용
      2. - 개인용
    • 신아바이오 공기살균기
      1. - 제품소개
      2. - 모델별 소개
      3. - 제품 인증서/시험성적서
    • 셀시우스TCS
  • 홍보센터
    • 공지사항/주요소식
    • 세미나/학회정보
  • 회원자료실
    • 문헌정보
    • Clinical Study
    • 뉴스레터
    • 마케팅자료실
  • CONTACT US
    • 구입/서비스문의
    • 온열치료 FAQ
    • 협력사
    • 오시는 길

회원자료실

  • 문헌정보
  • Clinical Study
  • 뉴스레터
  • 마케팅자료실

[heckel NEWSLETTER] 2025년 3월호 FILE HOT

1. Inaugural “heckel Public Zoom Meeting” Join us for the inaugural public Zoom meeting on heckel whole-body hyperthermia, open to all users and those interested in whole-body hyperthermia. This event marks the beginning of a series exploring various topics in the field. 10th of April, 2025, MEZ/CE...

마케팅팀 | 2025.04.04 | 조회 113

[heckel NEWSLETTER] 2024년 12월호 FILE HOT

1. European School of Thermotherapy April 14-16, 2025 in Rotterdam The European School of Thermotherapy offers an intensive three-day program focused on the scientific and clinical foundations of hyperthermia treatment - endorsed by ESTRO and ESHO. Distinguished international faculty will present com...

마케팅팀 | 2025.01.24 | 조회 213

[heckel NEWSLETTER] 2024년 06월호 FILE HOT

1) DEGRO 2024 – 13.-15. June in Kassel: Presentation of thermography-controlled wIRA superficial hyperthermia heckel shows the thermography-controlled wIRA superficial hyperthermia (hydrosun®TWH1500) at the 30th Congress of the German Society for Radiooncology (DEGRO) from 13th – 15th of June 2024...

마케팅팀 | 2024.07.02 | 조회 673

[heckel NEWSLETTER] 2023년 12월호 FILE HOT

1)Pancreatic cancer: Important role of moderate whole-body hyperthermia in combination with palliative chemotherapy Hohneck et al. published in 'Cancers' a retrospective analysis of 206 pancreatic cancer patients who were treated with palliative chemotherapy at the Öschelbronn Clinic from 2015-2019:...

마케팅팀 | 2024.01.02 | 조회 887

[heckel NEWSLETTER] 2023년 6월호 FILE HOT

1) New clinical study "Potential of Moderate Whole Body Hyperthermia to Enhance Response (POWER)" at Charite University Berlin A total of six different patient groups are included in the randomized phase II study, all with palliative therapy intentions (defined subgroups of patients with metastatic m...

마케팅팀 | 2023.06.21 | 조회 1171

[heckel NEWSLETTER] 2023년 3월호 FILE HOT

1. New publication of Vaupel et al. in Cancers on the multitude of mechanisms responsible for improving cancer oxygenation as radiosensitizing effect of hyperthermia Locoregional mild hyperthermia (mHT) of 39–42°C can increase the efficacy of radiotherapy, allowing for reduced total doses and toxic...

마케팅팀 | 2023.04.03 | 조회 1080
[ 1 ] 2 3 4 5

바이오메디신 주식회사

  • 이용약관
  • 개인정보취급방침
  • 이메일주소무단수집거부

주소 : (우:15807) 경기도 군포시 엘에스로 172, 708호 (금정동, 한림휴먼타워) | 회사명 : 바이오메디신 주식회사 | 대표이사 : 강상만 | 사업자등록번호 : 214-88-22523
Email : info@biomedisyn.kr | Tel : 031-383-3144 | Fax : 031-383-3166

Copyright ⓒ 바이오메디신 주식회사 All rights reserved. Designed & Programmed by WHOIS